Tag Archive | "Blood/Serum"

Biospecimen Analysis Call for Participants Posted

Dr. Mollenhauer: "[Cerebrospinal fluid] bears the possibility to reflect the underlying biology of the disease process." Find out what makes the PPMI biospecimens, like cerebrospinal fluid, so important to finding progression markers for PD.

Continue reading...

PPMI Annual Meeting 2015 Summary

Nearly 150 PPMI investigators, coordinators, study cores, patient advisory and steering committee members, sponsors, and industry partners from around the world met in New York City May 13-14, 2015 to share PPMI updates and to discuss the future of the initiative. View the meeting's presentations.

Continue reading...

2015 Sample Request Rolling Application Deadlines

Qualified researchers can request access to PPMI biospecimens through the rolling application process. Mark your calendars with the 2015 schedule to ensure timely submission and review.

Continue reading...

PPMI Biosamples Webinar Posted

PPMI's principal investigator, Ken Marek, MD, and The Michael J. Fox Foundation's Mark Frasier, PhD held the PPMI Progress Update: Available Data and Biosamples webinar, covering an overview of PPMI, some initial findings, and the process for accessing the PPMI clinical data, imaging data, and biospecimens. A recording of the webinar is now available.

Continue reading...

New Serum Data Ready to Download

Serum analysis data from Maria Teresa Pellecchia, MD of the University of Salerno is now live in the PPMI database. Qualified researchers can download this data at no cost.

Continue reading...

Webinar on Available Parkinson’s and Controls Biosamples

PPMI and The Michael J. Fox Foundation are hosting a webinar which will cover available PPMI samples and data and the process for requesting both. The webinar will take place Monday, December 15, 12 to 1 p.m. ET. Learn more and register today.

Continue reading...

Over 22,000 Samples Currently Available

PPMI has been actively collecting a wealth of biospecimens from the study participants, a group that has now grown to over 800 enrolled individuals. The samples are standardized, longitudinal, and available to qualified researchers conducting biomarker verification studies.

Continue reading...

Opportunity for Funding and Access to Data and Specimens

Using a single application, qualified researchers may request access to clinical data and biospecimens from a collection of studies exploring promising areas in Parkinson?s research, including PPMI. The Michael J. Fox Foundation for Parkinson?s Research (MJFF) is also offering funding for use and analysis of the available information and materials.  Applicants may request up to […]

Continue reading...

New Approved Specimen Request

A request for PPMI biospecimens has recently been approved by the Biospecimen Review Committee (BRC). The researchers at the University of Salerno will investigate the utility of IGF-1 levels and dopamine transporter (DaT) uptake as a biomarker for cognitive dysfunction in early PD by measuring IGF-1 in serum samples and analyzing DaT imaging data from 400 PD and 200 healthy control subjects at baseline.

Continue reading...

New Feature: PPMI Biospecimen Inventory

An inventory of available biospecimens in PPMI can now be accessed on www.ppmi-info.org. This regularly updated table reflects the number of samples that are currently available for analysis by visit and type of sample. This is a key tool for researchers looking to request specimens to be analyzed for biomarker verification studies. This inventory table now provides researchers with real-time numbers of specimens available before submitting a request.

Continue reading...